AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17611937 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 0
Study 15109971 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant-behavioral treatment plus cognitive coping skills training
Number of subjects: 148
Study 15109971 — intervention group
Group type: EXPERIMENTAL
Intervention: Group discussion
Number of subjects: 148
Study 15109971 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 148
Study 15109971 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 148
Study 12181375 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza immunization
Number of subjects: 0
Study 9655713 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME 170 mg
Number of subjects: 22
Study 9655713 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 22
Study 9655713 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NAME
Number of subjects: 22
Study 7640430 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 samples taken after slowing down blood flow rate (Qb) to 100 ml per min for 3 min (C2-100)
Number of subjects: 22
Study 7640430 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 samples taken after stopping the blood pump for 1 min (C2-100-stop)
Number of subjects: 22
Study 7640430 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 samples taken with Qb restored to 100 ml per min and the venous line clamped for 12 sec (C2-100-clamp)
Number of subjects: 22
Study 7640430 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 samples taken after slowing down blood flow rate (Qb) to 50 ml per min for 3 min (C2-50)
Number of subjects: 22
Study 7640430 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 samples taken after stopping the blood pump for 1 min (C2-50-stop)
Number of subjects: 22
Study 7640430 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 samples taken with Qb slowed down to 50 ml per min and the venous line clamped (C2-50-clamp)
Number of subjects: 22
Study 31808359 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal medial gastrocnemius release (PMGR)
Number of subjects: 36
Study 31808359 — intervention group
Group type: COMPARATOR
Intervention: Open plantar fasciotomy (OPF)
Number of subjects: 36
Study 29535132 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip
Number of subjects: 87
Study 29535132 — intervention group
Group type: COMPARATOR
Intervention: Mitral valve repair
Number of subjects: 87
Study 28784673 — intervention group
Group type: EXPERIMENTAL
Intervention: Finafloxacin (single doses of 200 to 1,000 mg)
Number of subjects: 58
Study 28784673 — intervention group
Group type: EXPERIMENTAL
Intervention: Finafloxacin (multiple doses of 600 to 1,000 mg)
Number of subjects: 58
Study 28784673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 26269239 — intervention group
Group type: EXPERIMENTAL
Intervention: Pakistani almonds (10 g/d)
Number of subjects: 150
Study 26269239 — intervention group
Group type: EXPERIMENTAL
Intervention: American almonds (10 g/d)
Number of subjects: 150
Study 26269239 — intervention group
Group type: COMPARATOR
Intervention: No intervention (NI)
Number of subjects: 150
Study 24037607 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual learning treatment for the amblyopic eye
Number of subjects: 20
Study 24037607 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study 21359508 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (8 mg)
Number of subjects: 16
Study 21359508 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (40 mg)
Number of subjects: 16
Study 21359508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19900256 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 668
Study 19900256 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alfa
Number of subjects: 668
Study 17349073 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA-rich diet (38% fat, 20% SFA)
Number of subjects: 59
Study 17349073 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-rich diet (30% fat, 55% CHO)
Number of subjects: 59
Study 17349073 — intervention group
Group type: COMPARATOR
Intervention: MUFA-rich diet (38% fat, 22% MUFA)
Number of subjects: 59
Study 15529479 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive work
Number of subjects: 103
Study 15529479 — intervention group
Group type: COMPARATOR
Intervention: Community-based activities
Number of subjects: 103
Study 15529479 — intervention group
Group type: COMPARATOR
Intervention: No regular daily activity
Number of subjects: 103
Study 11573525 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2 microg ml(‐1)
Number of subjects: 15
Study 11573525 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3 microg ml(‐1)
Number of subjects: 15
Study 11573525 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 4 microg ml(‐1)
Number of subjects: 15
Study 11573525 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 5 microg ml(‐1)
Number of subjects: 15
Study 9590490 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Recovery (ER) patients
Number of subjects: 23
Study 9590490 — intervention group
Group type: COMPARATOR
Intervention: Late Recovery (LR) patients
Number of subjects: 23
Study 9590490 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recovery of WBC
Number of subjects: 23
Study 7823493 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound vibration therapy with 2.5 kHz and 0.66 W/cm2 intensity
Number of subjects: 31
Study 2841742 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg once a day
Number of subjects: 237
Study 2841742 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin 5000 IU t.d.s.
Number of subjects: 237
Study 29386007 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA)
Number of subjects: 0
Study 29386007 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 28625372 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous implantable cardioverter defibrillator
Number of subjects: 0
Study 28625372 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 25965706 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban (60 mg QD or 30 mg QD depending on factors)
Number of subjects: 0
Study 25965706 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin/warfarin followed by warfarin alone
Number of subjects: 0
Study 23396280 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorapaxar (2.5 mg daily)
Number of subjects: 4883
Study 23396280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4883
Study 20925970 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (high-frequency rTMS delivered to the left dorsolateral prefrontal cortex)
Number of subjects: 22
Study 20925970 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 22
Study 20925970 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 22
Study 18178525 — intervention group
Group type: EXPERIMENTAL
Intervention: IGIV-C (Gamunex)
Number of subjects: 117
Study 18178525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 16641607 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin + Resistance Exercise
Number of subjects: 18
Study 16641607 — intervention group
Group type: COMPARATOR
Intervention: Calcitonin
Number of subjects: 18
Study 14640385 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 101
Study 10992845 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 litre of crystalloid preload (Group 1)
Number of subjects: 95
Study 10992845 — intervention group
Group type: COMPARATOR
Intervention: No preload (Group 2)
Number of subjects: 95
Study 8774216 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fibre extracted from pea hulls
Number of subjects: 0
Study 8774216 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fibre extracted from carrots
Number of subjects: 0
Study 8774216 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (control)
Number of subjects: 0
Study 1476763 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 0
Study 1476763 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 6378895 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 66
Study 6378895 — intervention group
Group type: COMPARATOR
Intervention: Doxepin
Number of subjects: 66
Study 31449880 — intervention group
Group type: EXPERIMENTAL
Intervention: TX Sprouts intervention (gardening, nutrition, and cooking activities)
Number of subjects: 3137
Study 31449880 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (same protocol as intervention arm)
Number of subjects: 3137
Study 29330461 — intervention group
Group type: EXPERIMENTAL
Intervention: C4 dietary oil (10.7 g) plus 200 g carrot
Number of subjects: 13
Study 29330461 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil (19 g) plus 200 g carrot
Number of subjects: 13
Study 29330461 — intervention group
Group type: COMPARATOR
Intervention: Carrot (200 g)
Number of subjects: 13
Study 27856377 — intervention group
Group type: EXPERIMENTAL
Intervention: Erbium-YAG laser
Number of subjects: 24
Study 27856377 — intervention group
Group type: COMPARATOR
Intervention: Control group (no laser)
Number of subjects: 24
Study 25036538 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Through Distress (LTD) programme, a DBT-informed skills group
Number of subjects: 82
Study 25036538 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) group
Number of subjects: 82
Study 25036538 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Through Distress (LTD) programme
Number of subjects: 82
Study 22932281 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA and DHA supplementation (1, 2, or 4 times/week)
Number of subjects: 204
Study 22932281 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA and DHA supplementation
Number of subjects: 204
Study 22932281 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma phosphatidylcholine EPA plus DHA
Number of subjects: 204
Study 22932281 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet and mononuclear cell EPA plus DHA
Number of subjects: 204
Study 20953791 — intervention group
Group type: EXPERIMENTAL
Intervention: GA 20 mg/0.5 mL (reduced volume formulation)
Number of subjects: 0
Study 20953791 — intervention group
Group type: COMPARATOR
Intervention: GA 20 mg/1.0 mL (marketed formulation)
Number of subjects: 0
Study 16947012 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFS) with three doses of mesna
Number of subjects: 33
Study 14965885 — intervention group
Group type: EXPERIMENTAL
Intervention: Safer Bars intervention
Number of subjects: 734
Study 14965885 — intervention group
Group type: COMPARATOR
Intervention: Control bars
Number of subjects: 734
Study 11503471 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings (compression class 2, 25‐35 mmHg at the ankle)
Number of subjects: 22
Study 11503471 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression stockings (compression class 2)
Number of subjects: 22
Study 9512251 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-culture with assisted hatching
Number of subjects: 200
Study 9512251 — intervention group
Group type: COMPARATOR
Intervention: Control (no co-culture)
Number of subjects: 200
Study 9512251 — intervention group
Group type: COMPARATOR
Intervention: ICSI or ICSI/IVF
Number of subjects: 200
Study 7848788 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg
Number of subjects: 147
Study 7848788 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg
Number of subjects: 147
Study 7848788 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 147
Study 7848788 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 147
Study 7848788 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Diltiazem 120 mg + Enalapril 10 mg)
Number of subjects: 147
Study 7848788 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 147
Study 7848788 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 147
Study 7848788 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 147
Study 3057139 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal steroids (20 mg dexamethasone)
Number of subjects: 335
Study 3057139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study 30826266 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic stimulation (CHR)
Number of subjects: 12
Study 30826266 — intervention group
Group type: COMPARATOR
Intervention: Experimental stimulation (EXP)
Number of subjects: 12
Study 29703087 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser navigation system
Number of subjects: 75
Study 29703087 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopic imaging
Number of subjects: 75
Study 27135465 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine injection
Number of subjects: 28
Study 27135465 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency treatment
Number of subjects: 28
Study 27135465 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 28
Study 24479702 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) carried out by a GP
Number of subjects: 750
Study 24479702 — intervention group
Group type: COMPARATOR
Intervention: Routine medical care (Control)
Number of subjects: 750
Study 24479702 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 750
Study 22296076 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg ulipristal acetate
Number of subjects: 307
Study 22296076 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ulipristal acetate
Number of subjects: 307
Study 22296076 — intervention group
Group type: COMPARATOR
Intervention: leuprolide acetate
Number of subjects: 307
Study 20659392 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHA-P)
Number of subjects: 149
Study 20659392 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 149
Study 17208307 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.15 mg/kg
Number of subjects: 41
Study 17208307 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 0.6 mg/kg
Number of subjects: 41
Study 16157934 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 3612
Study 16157934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3612
Study 12450895 — intervention group
Group type: EXPERIMENTAL
Intervention: Men born short (≤ 50.5 cm) who became tall adults (175‐180.5 cm)
Number of subjects: 4775
Study 12450895 — intervention group
Group type: EXPERIMENTAL
Intervention: Men born short (≤ 50.5 cm) who became tall adults (> 180.5 cm)
Number of subjects: 4775
Study 12450895 — intervention group
Group type: COMPARATOR
Intervention: Birth length
Number of subjects: 4775
Study 12450895 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 4775
Study 10095921 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipole (Lactobacillus acidophilus + Kefir greins)
Number of subjects: 120
Study 10095921 — intervention group
Group type: COMPARATOR
Intervention: Routine antibiotics
Number of subjects: 120
Study 7759449 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic (0.5% bupivacaine hydrochloride) injected into the base of the fourth finger
Number of subjects: 5
Study 7759449 — intervention group
Group type: COMPARATOR
Intervention: Saline injected into the base of the index finger
Number of subjects: 5
Study 2275322 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 43
Study 2275322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 377448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg/day)
Number of subjects: 55
Study 377448 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (1200 mg/day)
Number of subjects: 55
Study 31800551 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical decompression
Number of subjects: 30
Study 31800551 — intervention group
Group type: COMPARATOR
Intervention: Mega dose corticosteroid (30 mg/kg stat and 15 mg/kg every 6 hours for 3 days)
Number of subjects: 30
Study 31800551 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 30973544 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART (initiated at a median of 6 days)
Number of subjects: 1134
Study 30973544 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART (initiated at a median of 699 days)
Number of subjects: 1134
Study 30973544 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART
Number of subjects: 1134
Study 30973544 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous virologic suppression
Number of subjects: 1134
Study 28470106 — intervention group
Group type: EXPERIMENTAL
Intervention: NEUROD2 polymorphism rs11078918
Number of subjects: 167
Study 28470106 — intervention group
Group type: EXPERIMENTAL
Intervention: NEUROD2 polymorphism rs12453682
Number of subjects: 167
Study 28470106 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in neuropsychological test results during antipsychotic treatment
Number of subjects: 167
Study 26152326 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal home-based psychoeducative intervention (single session + telephone booster)
Number of subjects: 66
Study 26152326 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study 24850465 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-based diet (n-3 PUFAs ≧ 3.0 g/day)
Number of subjects: 23
Study 24850465 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 23
Study 22702523 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fidaxomicin for 10 days
Number of subjects: 0
Study 22702523 — intervention group
Group type: COMPARATOR
Intervention: Oral vancomycin
Number of subjects: 0
Study 20034916 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with docetaxel combined with pirarubicin (TThp)
Number of subjects: 120
Study 20034916 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with docetaxel combined with epirubicin (TE)
Number of subjects: 120
Study 20034916 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (both regimens)
Number of subjects: 120
Study 17869373 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric test battery
Number of subjects: 217
Study 17869373 — intervention group
Group type: EXPERIMENTAL
Intervention: Portosystemic-Encephalopathy-Syndrome (PSE) test
Number of subjects: 217
Study 17869373 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric-Hepatic-Encephalopathy-Sum (PHES)-score
Number of subjects: 217
Study 17869373 — intervention group
Group type: EXPERIMENTAL
Intervention: Number-connection-tests-A
Number of subjects: 217
Study 17869373 — intervention group
Group type: EXPERIMENTAL
Intervention: Number-connection-tests-B
Number of subjects: 217
Study 17869373 — intervention group
Group type: EXPERIMENTAL
Intervention: Line-tracing-test
Number of subjects: 217
Study 15076172 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril treatment
Number of subjects: 10985
Study 15076172 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril therapy
Number of subjects: 10985
Study 15076172 — intervention group
Group type: COMPARATOR
Intervention: Conventional diuretic and/or beta-blocker therapy
Number of subjects: 10985
Study 12034161 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary, home-based intervention (HBI)
Number of subjects: 90
Study 10360293 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, 40 mg, administered 1 hour prior to surgery
Number of subjects: 5
Study 10360293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 7731628 — intervention group
Group type: EXPERIMENTAL
Intervention: New therapeutic options for conservative treatment of vulvar lichen sclerosus
Number of subjects: 0
Study 2654435 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week aerobic exercise program at 70% of maximal heart rate
Number of subjects: 16
Study 2654435 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 466329 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment from qualified speech therapists
Number of subjects: 0
Study 466329 — intervention group
Group type: COMPARATOR
Intervention: Treatment from non‐professional volunteers
Number of subjects: 0
Study 31829912 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant ADT for 6 months starting 4 months before RT
Number of subjects: 432
Study 31829912 — intervention group
Group type: COMPARATOR
Intervention: Concurrent ADT for 6 months starting simultaneously with RT
Number of subjects: 432
Study 31136069 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure (LP; 8 mmHg)
Number of subjects: 178
Study 31136069 — intervention group
Group type: COMPARATOR
Intervention: Standard pressure (SP; 15 mmHg, control)
Number of subjects: 178
Study 28938962 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants
Number of subjects: 2281
Study 28938962 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oral anticoagulants and antiplatelet drugs
Number of subjects: 2281
Study 25962329 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cooling (intermittent immersion in 14°C water until rectal temperature reached 35.5°C or for a maximum of 170 min)
Number of subjects: 32
Study 25962329 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cooling
Number of subjects: 32
Study 23412808 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal/pharmaceutical supplements
Number of subjects: 132
Study 23412808 — intervention group
Group type: COMPARATOR
Intervention: Referents (age-matched female subjects, n=128)
Number of subjects: 132
Study 16778330 — intervention group
Group type: EXPERIMENTAL
Intervention: New DeltaBP-estimation device (BP-ECG monitor)
Number of subjects: 293